• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 204 个国家和地区 1990 年至 2019 年卫生服务有效覆盖指数测量全民健康覆盖:2019 年全球疾病负担研究的系统分析。

Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

出版信息

Lancet. 2020 Oct 17;396(10258):1250-1284. doi: 10.1016/S0140-6736(20)30750-9. Epub 2020 Aug 27.

DOI:10.1016/S0140-6736(20)30750-9
PMID:32861314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7562819/
Abstract

BACKGROUND

Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system level is important for understanding whether health services are aligned with countries' health profiles and are of sufficient quality to produce health gains for populations of all ages.

METHODS

Based on the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we assessed UHC effective coverage for 204 countries and territories from 1990 to 2019. Drawing from a measurement framework developed through WHO's GPW13 consultation, we mapped 23 effective coverage indicators to a matrix representing health service types (eg, promotion, prevention, and treatment) and five population-age groups spanning from reproductive and newborn to older adults (≥65 years). Effective coverage indicators were based on intervention coverage or outcome-based measures such as mortality-to-incidence ratios to approximate access to quality care; outcome-based measures were transformed to values on a scale of 0-100 based on the 2·5th and 97·5th percentile of location-year values. We constructed the UHC effective coverage index by weighting each effective coverage indicator relative to its associated potential health gains, as measured by disability-adjusted life-years for each location-year and population-age group. For three tests of validity (content, known-groups, and convergent), UHC effective coverage index performance was generally better than that of other UHC service coverage indices from WHO (ie, the current metric for SDG indicator 3.8.1 on UHC service coverage), the World Bank, and GBD 2017. We quantified frontiers of UHC effective coverage performance on the basis of pooled health spending per capita, representing UHC effective coverage index levels achieved in 2019 relative to country-level government health spending, prepaid private expenditures, and development assistance for health. To assess current trajectories towards the GPW13 UHC billion target-1 billion more people benefiting from UHC by 2023-we estimated additional population equivalents with UHC effective coverage from 2018 to 2023.

FINDINGS

Globally, performance on the UHC effective coverage index improved from 45·8 (95% uncertainty interval 44·2-47·5) in 1990 to 60·3 (58·7-61·9) in 2019, yet country-level UHC effective coverage in 2019 still spanned from 95 or higher in Japan and Iceland to lower than 25 in Somalia and the Central African Republic. Since 2010, sub-Saharan Africa showed accelerated gains on the UHC effective coverage index (at an average increase of 2·6% [1·9-3·3] per year up to 2019); by contrast, most other GBD super-regions had slowed rates of progress in 2010-2019 relative to 1990-2010. Many countries showed lagging performance on effective coverage indicators for non-communicable diseases relative to those for communicable diseases and maternal and child health, despite non-communicable diseases accounting for a greater proportion of potential health gains in 2019, suggesting that many health systems are not keeping pace with the rising non-communicable disease burden and associated population health needs. In 2019, the UHC effective coverage index was associated with pooled health spending per capita (r=0·79), although countries across the development spectrum had much lower UHC effective coverage than is potentially achievable relative to their health spending. Under maximum efficiency of translating health spending into UHC effective coverage performance, countries would need to reach $1398 pooled health spending per capita (US$ adjusted for purchasing power parity) in order to achieve 80 on the UHC effective coverage index. From 2018 to 2023, an estimated 388·9 million (358·6-421·3) more population equivalents would have UHC effective coverage, falling well short of the GPW13 target of 1 billion more people benefiting from UHC during this time. Current projections point to an estimated 3·1 billion (3·0-3·2) population equivalents still lacking UHC effective coverage in 2023, with nearly a third (968·1 million [903·5-1040·3]) residing in south Asia.

INTERPRETATION

The present study demonstrates the utility of measuring effective coverage and its role in supporting improved health outcomes for all people-the ultimate goal of UHC and its achievement. Global ambitions to accelerate progress on UHC service coverage are increasingly unlikely unless concerted action on non-communicable diseases occurs and countries can better translate health spending into improved performance. Focusing on effective coverage and accounting for the world's evolving health needs lays the groundwork for better understanding how close-or how far-all populations are in benefiting from UHC.

FUNDING

Bill & Melinda Gates Foundation.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/f4319dbcd231/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/d97a3ceedc9f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/3feaac6ee90e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/37876c3e70f1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/988796d04f96/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/7432c2c62500/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/f4319dbcd231/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/d97a3ceedc9f/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/3feaac6ee90e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/37876c3e70f1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/988796d04f96/gr4a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/7432c2c62500/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/7562819/f4319dbcd231/gr6.jpg
摘要

背景

实现全民健康覆盖(UHC)涉及所有人都能获得高质量的卫生服务,而不会面临经济困难。推进 UHC 是国家和全球机构的政策优先事项,这一点在联合国可持续发展目标(SDG)和世卫组织第十三届总规划(GPW13)议程中得到了强调。衡量卫生系统层面的有效覆盖情况对于了解卫生服务是否与各国的卫生状况相符,以及是否足以改善各年龄段人群的健康状况非常重要。

方法

我们根据 2019 年全球疾病、伤害和风险因素研究(GBD),评估了 204 个国家和地区从 1990 年到 2019 年的 UHC 有效覆盖情况。根据世卫组织 GPW13 咨询会议制定的测量框架,我们将 23 个有效覆盖指标映射到一个代表卫生服务类型(如促进、预防和治疗)和五个涵盖从生殖和新生儿到老年人(≥65 岁)的人口年龄组的矩阵上。有效覆盖指标基于干预覆盖或基于结果的措施,例如死亡率与发病率的比值,以近似获得高质量的护理;基于结果的措施被转换为基于位置-年份值的 2.5%和 97.5%分位数的 0-100 之间的值。我们通过将每个有效覆盖指标相对于与其相关的潜在健康收益进行加权,构建了 UHC 有效覆盖指数,这些潜在健康收益是根据每个位置-年份和人口年龄组的残疾调整生命年来衡量的。对于三项有效性测试(内容、已知群体和收敛性),UHC 有效覆盖指数的表现总体上优于世卫组织(即,SDG 指标 3.8.1 关于 UHC 服务覆盖的当前指标)、世界银行和 GBD 2017 的其他 UHC 服务覆盖指数。我们根据人均卫生支出的前沿水平,量化了 2019 年 UHC 有效覆盖指数水平相对于国家一级政府卫生支出、预付款私人支出和卫生发展援助所实现的 UHC 有效覆盖的情况,代表了 2019 年 UHC 有效覆盖的情况。为了评估到 2023 年实现 GPW13 UHC 十亿目标——使 10 亿人受益于 UHC 的当前轨迹,我们估计了 2018 年至 2023 年期间 UHC 有效覆盖的额外人口当量。

发现

全球范围内,UHC 有效覆盖指数从 1990 年的 45.8(95%不确定性区间 44.2-47.5)提高到 2019 年的 60.3(58.7-61.9),但 2019 年各国的 UHC 有效覆盖范围仍从日本和冰岛的 95 或更高,到索马里和中非共和国的低于 25。自 2010 年以来,撒哈拉以南非洲地区在 UHC 有效覆盖指数方面的增长速度加快(平均每年增长 2.6%[1.9-3.3],直至 2019 年);相比之下,2010-2019 年期间,大多数其他 GBD 超级区域的进展速度都有所放缓。尽管非传染性疾病在 2019 年占潜在健康收益的比例更大,表明许多卫生系统没有跟上非传染性疾病负担不断增加和相关人口健康需求的步伐,但许多国家在非传染性疾病有效覆盖指标方面的表现滞后于传染性疾病和母婴健康方面的表现。2019 年,UHC 有效覆盖指数与人均卫生支出(r=0.79)相关,尽管各国在卫生支出方面的发展情况各不相同,但与实现 UHC 的潜在支出相比,它们的 UHC 有效覆盖水平要低得多。在最大效率地将卫生支出转化为 UHC 有效覆盖绩效的情况下,各国需要达到人均 1398 美元的卫生支出(经购买力平价调整后的美元),才能使 UHC 有效覆盖指数达到 80。从 2018 年到 2023 年,估计将有 3.889 亿(3.586-4.213)更多的人口当量具有 UHC 有效覆盖,远低于 GPW13 在这段时间内使 10 亿人受益于 UHC 的目标。目前的预测表明,到 2023 年,仍将有估计的 31 亿(3.0-3.2)人口当量缺乏 UHC 有效覆盖,其中近三分之一(968.1 万[903.5-1040.3])居住在南亚。

解释

本研究表明,衡量有效覆盖及其在支持所有人获得更好健康结果方面的作用的效用,这是 UHC 的最终目标及其实现。除非在非传染性疾病方面采取协调一致的行动,各国能够更好地将卫生支出转化为改善的绩效,否则全球加快推进 UHC 服务覆盖的雄心壮志不太可能实现。关注有效覆盖,并考虑世界不断变化的健康需求,为更好地了解所有人群距离或离受益于 UHC 还有多远奠定了基础。

资金来源

比尔及梅琳达·盖茨基金会。

相似文献

1
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.基于 204 个国家和地区 1990 年至 2019 年卫生服务有效覆盖指数测量全民健康覆盖:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1250-1284. doi: 10.1016/S0140-6736(20)30750-9. Epub 2020 Aug 27.
2
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016.基于过去健康相关可持续发展目标趋势衡量进展和预测完成情况:来自 2016 年全球疾病负担研究的分析。
Lancet. 2017 Sep 16;390(10100):1423-1459. doi: 10.1016/S0140-6736(17)32336-X. Epub 2017 Sep 12.
3
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.衡量 195 个国家和地区及部分次国家级地点的医疗卫生可得性和质量指数的表现:来自 2016 年全球疾病负担研究的系统分析。
Lancet. 2018 Jun 2;391(10136):2236-2271. doi: 10.1016/S0140-6736(18)30994-2. Epub 2018 Jun 1.
4
Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017.衡量 1990 年至 2017 年期间的进展情况,并预测 195 个国家和地区在 2030 年实现与健康相关的可持续发展目标的情况:基于 2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):2091-2138. doi: 10.1016/S0140-6736(18)32281-5. Epub 2018 Nov 8.
5
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.预测 250 种死因的预期寿命、损失的生命年数以及全因和特定死因死亡率:2016-2040 年 195 个国家和地区的参考和替代情景。
Lancet. 2018 Nov 10;392(10159):2052-2090. doi: 10.1016/S0140-6736(18)31694-5. Epub 2018 Oct 16.
6
Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.衡量卫生人力资源的可及性及其与 1990 年至 2019 年 204 个国家和地区全民健康覆盖的关系:2019 年全球疾病负担研究的系统分析。
Lancet. 2022 Jun 4;399(10341):2129-2154. doi: 10.1016/S0140-6736(22)00532-3. Epub 2022 May 23.
7
Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016-40.未来卫生筹资和覆盖范围趋势:188 个国家 2016-40 年未来卫生支出和全民健康覆盖
Lancet. 2018 May 5;391(10132):1783-1798. doi: 10.1016/S0140-6736(18)30697-4. Epub 2018 Apr 17.
8
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.基于1990 - 2015年195个国家和地区可通过个人医疗保健预防的死因的医疗保健可及性和质量指数:全球疾病负担研究2015的一项新分析
Lancet. 2017 Jul 15;390(10091):231-266. doi: 10.1016/S0140-6736(17)30818-8. Epub 2017 May 18.
9
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.204 个国家和地区 2022-2050 年疾病负担情景:2021 年全球疾病负担研究的预测分析。
Lancet. 2024 May 18;403(10440):2204-2256. doi: 10.1016/S0140-6736(24)00685-8.
10
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.全球疾病、伤害和危险因素负担研究 2021 年,1990-2021 年全球 204 个国家和地区及 811 个次国家地区 371 种疾病和伤害的发病率、患病率、伤残损失生命年(YLDs)、伤残调整生命年(DALYs)以及健康期望寿命(HALE):系统分析
Lancet. 2024 May 18;403(10440):2133-2161. doi: 10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17.

引用本文的文献

1
Trends and inequalities in the global burden of alzheimer's disease and other dementias, 1990-2021: a Chinese perspective.1990 - 2021年全球阿尔茨海默病及其他痴呆症负担的趋势与不平等:中国视角
BMC Public Health. 2025 Aug 30;25(1):2977. doi: 10.1186/s12889-025-24097-x.
2
Return to normal activity after abdominal surgery: a pre-planned secondary analysis of a randomised controlled trial across seven low- and middle-income countries.腹部手术后恢复正常活动:一项针对七个低收入和中等收入国家的随机对照试验的预先计划的二次分析
BMC Surg. 2025 Aug 29;25(1):399. doi: 10.1186/s12893-025-03079-1.
3
Global burden of peripheral arterial disease and its risk factors, 1990-2021.

本文引用的文献

1
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 87 种风险因素的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2.
2
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
3
1990 - 2021年全球外周动脉疾病及其风险因素的负担
BMC Cardiovasc Disord. 2025 Aug 26;25(1):631. doi: 10.1186/s12872-025-05055-2.
4
Contribution of dental prostheses on the association between dental visits and self- reported chewing ability among older Japanese adults: a cross-sectional study.假牙对日本老年人就诊牙科与自我报告的咀嚼能力之间关联的影响:一项横断面研究。
BMC Oral Health. 2025 Aug 23;25(1):1363. doi: 10.1186/s12903-025-06673-0.
5
Non-medical costs incurred by critically ill patients with dengue, sepsis and tetanus within a major referral hospital in Southern Vietnam: a cost of illness study.越南南部一家大型转诊医院中登革热、败血症和破伤风重症患者的非医疗费用:一项疾病成本研究。
BMJ Public Health. 2025 Aug 20;3(2):e002169. doi: 10.1136/bmjph-2024-002169. eCollection 2025.
6
Global, regional, and national burden of neonatal infectious diseases from 1990 to 2021.1990年至2021年全球、区域和国家新生儿传染病负担
Transl Pediatr. 2025 Jul 31;14(7):1498-1510. doi: 10.21037/tp-2025-57. Epub 2025 Jul 28.
7
Comparative analysis of metabolic risks and related non-communicable disease burden across sociodemographic index regions from 1990 to 2021.1990年至2021年不同社会人口学指数地区代谢风险及相关非传染性疾病负担的比较分析
BMJ Open. 2025 Aug 10;15(8):e097748. doi: 10.1136/bmjopen-2024-097748.
8
Impact of COVID-19 vaccination coverage on global disability burden of Guillain-Barré syndrome.新型冠状病毒肺炎疫苗接种覆盖率对吉兰-巴雷综合征全球残疾负担的影响
NPJ Vaccines. 2025 Aug 2;10(1):182. doi: 10.1038/s41541-025-01239-1.
9
My Back Exercise app: an automated exercise intervention supported by educational notifications, a sleep programme and diet advice to improve function in people with chronic non-specific low back pain - protocol for a superiority, adaptive multi-arm multi-stage randomised controlled trial.我的背部锻炼应用程序:一项由教育通知、睡眠计划和饮食建议支持的自动化锻炼干预措施,旨在改善慢性非特异性下腰痛患者的功能——一项优效性、适应性多组多阶段随机对照试验方案
BMJ Open. 2025 Aug 1;15(7):e098324. doi: 10.1136/bmjopen-2024-098324.
10
Revisiting Alma Ata: A Blueprint for Cancer Care.重温阿拉木图宣言:癌症护理蓝图
Cancer Control. 2025 Jan-Dec;32:10732748251363701. doi: 10.1177/10732748251363701. Epub 2025 Jul 30.
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
204 个国家和地区 1950-2019 年全球年龄性别特定生育率、死亡率、健康期望寿命(HALE)和人口估计值:2019 年全球疾病负担研究的综合人口分析。
Lancet. 2020 Oct 17;396(10258):1160-1203. doi: 10.1016/S0140-6736(20)30977-6.
4
Five insights from the Global Burden of Disease Study 2019.2019 年全球疾病负担研究的五个洞见。
Lancet. 2020 Oct 17;396(10258):1135-1159. doi: 10.1016/S0140-6736(20)31404-5.
5
Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study.2017 年至 2100 年 195 个国家和地区的生育率、死亡率、迁移和人口预测情景:全球疾病负担研究的预测分析。
Lancet. 2020 Oct 17;396(10258):1285-1306. doi: 10.1016/S0140-6736(20)30677-2. Epub 2020 Jul 14.
6
Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.卫生部门支出以及在艾滋病毒/艾滋病、结核病和疟疾方面的支出和用于卫生的发展援助:在实现可持续发展目标 3 方面的进展。
Lancet. 2020;396(10252):693-724. doi: 10.1016/S0140-6736(20)30608-5. Epub 2020 Apr 23.
7
A comprehensive assessment of universal health coverage in 111 countries: a retrospective observational study.111 个国家全民健康覆盖情况的综合评估:回顾性观察研究。
Lancet Glob Health. 2020 Jan;8(1):e39-e49. doi: 10.1016/S2214-109X(19)30463-2. Epub 2019 Dec 11.
8
Measurement matters: who and what counts on the road to universal health coverage.衡量至关重要:在全民健康覆盖之路上,谁重要,什么重要。
Lancet Glob Health. 2020 Jan;8(1):e2-e3. doi: 10.1016/S2214-109X(19)30499-1. Epub 2019 Dec 11.
9
Monitoring the health-related Sustainable Development Goals: lessons learned and recommendations for improved measurement.监测与健康相关的可持续发展目标:经验教训及改进测量的建议
Lancet. 2020 Jan 18;395(10219):240-246. doi: 10.1016/S0140-6736(19)32523-1. Epub 2019 Nov 22.
10
Monitoring Frameworks for Universal Health Coverage: What About High-Income Countries?全民健康覆盖监测框架:高收入国家如何?
Int J Health Policy Manag. 2019 Jul 1;8(7):387-393. doi: 10.15171/ijhpm.2019.21.